Vir Biotechnology, Inc.
VIR
$4.38
$0.020.46%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.00M | 20.86M | 74.21M | 78.62M | 78.88M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.00M | 20.86M | 74.21M | 78.62M | 78.88M |
| Cost of Revenue | 499.15M | 506.80M | 487.72M | 505.30M | 455.13M |
| Gross Profit | -480.15M | -485.94M | -413.51M | -426.68M | -376.26M |
| SG&A Expenses | 98.67M | 106.65M | 119.03M | 133.55M | 148.74M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 597.82M | 613.45M | 606.75M | 638.84M | 603.87M |
| Operating Income | -578.82M | -592.59M | -532.54M | -560.23M | -524.99M |
| Income Before Tax | -549.95M | -579.05M | -523.11M | -539.19M | -492.27M |
| Income Tax Expenses | 277.00K | -1.41M | -1.15M | -5.84M | -9.23M |
| Earnings from Continuing Operations | -550.23 | -577.65 | -521.96 | -533.34 | -483.04 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | 0.00 | 0.00 |
| Net Income | -550.23M | -577.65M | -521.96M | -533.34M | -483.04M |
| EBIT | -578.82M | -592.59M | -532.54M | -560.23M | -524.99M |
| EBITDA | -567.26M | -579.68M | -517.98M | -544.07M | -507.15M |
| EPS Basic | -4.01 | -4.22 | -3.83 | -3.92 | -3.58 |
| Normalized Basic EPS | -2.39 | -2.43 | -2.12 | -2.23 | -2.05 |
| EPS Diluted | -4.01 | -4.22 | -3.83 | -3.93 | -3.58 |
| Normalized Diluted EPS | -2.39 | -2.43 | -2.12 | -2.23 | -2.05 |
| Average Basic Shares Outstanding | 549.38M | 547.16M | 544.97M | 542.77M | 540.40M |
| Average Diluted Shares Outstanding | 549.38M | 547.16M | 544.97M | 542.77M | 540.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |